Every record from VendorInvestigate · page 2
The only contributor that routinely purchases material anonymously rather than accepting submitted samples. Measured offset against the reference laboratory is -0.493 pp on 380 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043077 | Tirzepatide | KP | KP-2605-E6030 | 2026-Q2 | 97.44 | 3.57 | 91.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043299 | IGF-1 LR3 | CPC | CPC-2512-S2394 | 2026-Q2 | 97.29 | 1.77 | 96.7 | Buyer-sourced | 1 | FAIL |
| AX-2026-041598 | Dihexa | QSC | QSC-2512-D7108 | 2026-Q2 | 98.98 | 6.85 | 99.4 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042916 | Gonadorelin | MKM | MKM-2604-A2596 | 2026-Q2 | 99.36 | 4.91 | 102.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043390 | BPC-157 | WXT | WXT-2603-K3648 | 2026-Q2 | 97.74 | 4.42 | 96.8 | Buyer-sourced | 1 | FAIL |
| AX-2026-042634 | Semaglutide | GGPeps | GGPE-2603-W8751 | 2026-Q2 | 99.92 | 3.53 | 97.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041305 | Ipamorelin | WWB | WWB-2604-E3153 | 2026-Q2 | 99.93 | 5.90 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041531 | BPC-157 | QYB | QYB-2601-H6381 | 2026-Q2 | 99.85 | 2.34 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041520 | Retatrutide | QYB | QYB-2602-R6263 | 2026-Q2 | 97.53 | 5.39 | 100.7 | Buyer-sourced | 0 | PASS |
| AX-2026-043242 | Melanotan II | SGN | SGN-2602-L1809 | 2026-Q2 | 98.14 | 2.18 | 107.2 | Buyer-sourced | 1 | FAIL |
| AX-2026-043170 | BPC-157 | GL Biochem | GLBI-2602-T8420 | 2026-Q2 | 98.70 | 4.79 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042093 | PT-141 (Bremelanotide) | TFC | TFC-2512-V7681 | 2026-Q2 | 98.40 | 3.31 | 100.6 | Buyer-sourced | 0 | FAIL |
| AX-2026-043296 | IGF-1 LR3 | CPC | CPC-2512-S2394 | 2026-Q2 | 97.80 | 2.30 | 91.3 | Buyer-sourced | 0 | PASS |
| AX-2026-042951 | Semaglutide | KP | KP-2601-K4658 | 2026-Q2 | 98.13 | 6.11 | 91.2 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043048 | Hexarelin | KP | KP-2604-X5435 | 2026-Q2 | 98.28 | 3.15 | 94.2 | Buyer-sourced | 2 | FAIL |
| AX-2026-041763 | CJC-1295 (no DAC) | FGP | FGP-2601-V1242 | 2026-Q2 | 99.93 | 5.48 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043019 | Semaglutide | KP | KP-2511-J4998 | 2026-Q2 | 99.44 | 7.58 | 94.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042285 | Semaglutide | Homopeptide | HOMO-2604-M2254 | 2026-Q2 | 98.17 | 2.79 | 105.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043142 | Semax | SSA | SSA-2604-L7628 | 2026-Q2 | 98.30 | 8.24 | — | Buyer-sourced | 2 | FAIL |
| AX-2026-041524 | BPC-157 | QYB | QYB-2601-H6381 | 2026-Q2 | 99.93 | 1.87 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042701 | Semaglutide | GGPeps | GGPE-2604-L9412 | 2026-Q2 | 98.34 | 5.66 | 92.1 | Buyer-sourced | 0 | PASS |
| AX-2026-041266 | Semaglutide | WWB | WWB-2603-W2120 | 2026-Q2 | 99.39 | 4.10 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-043343 | TB-500 | CPC | CPC-2605-B2433 | 2026-Q2 | 97.95 | 5.97 | 104.0 | Buyer-sourced | 3 | FAIL |
| AX-2026-042658 | Semax | GGPeps | GGPE-2512-Y8309 | 2026-Q2 | 98.83 | 7.19 | 104.0 | Buyer-sourced | 0 | PASS |
| AX-2026-041778 | SS-31 (Elamipretide) | FGP | FGP-2601-R1916 | 2026-Q2 | 99.42 | 4.05 | 90.3 | Buyer-sourced | 0 | PASS |
| AX-2026-043184 | PT-141 (Bremelanotide) | GL Biochem | GLBI-2511-F8417 | 2026-Q2 | 97.67 | 3.01 | 99.8 | Buyer-sourced | 2 | FAIL |
| AX-2026-042809 | Retatrutide | GGPeps | GGPE-2603-M1446 | 2026-Q2 | 97.14 | 4.06 | 93.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041405 | Retatrutide | WWB | WWB-2512-S4435 | 2026-Q2 | 98.11 | 4.54 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041367 | Semaglutide | WWB | WWB-2512-T3671 | 2026-Q2 | 98.57 | 2.57 | 102.4 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-043081 | Tirzepatide | KP | KP-2605-E6030 | 2026-Q2 | 97.55 | 4.21 | 91.4 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041716 | Exenatide | QSC | QSC-2602-P9435 | 2026-Q2 | 98.64 | 5.35 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042821 | TB-500 | GGPeps | GGPE-2605-J2051 | 2026-Q2 | 98.71 | 5.12 | 106.0 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042998 | TB-500 | KP | KP-2605-C4659 | 2026-Q2 | 98.72 | 6.21 | 95.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042623 | KPV | GGPeps | GGPE-2511-K8830 | 2026-Q2 | 97.47 | 5.07 | 103.3 | Buyer-sourced | 1 | FAIL |
| AX-2026-041608 | Pinealon | QSC | QSC-2602-V8219 | 2026-Q2 | 99.93 | 7.95 | 106.0 | Buyer-sourced | 0 | PASS |
| AX-2026-041308 | Ipamorelin | WWB | WWB-2604-E3153 | 2026-Q2 | 99.93 | 6.24 | 103.9 | Buyer-sourced | 0 | PASS |
| AX-2026-043384 | Sermorelin | CPC | CPC-2605-N3532 | 2026-Q2 | 98.47 | 4.73 | 95.5 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042324 | Tirzepatide | HJ | HJ-2605-D3120 | 2026-Q2 | 98.11 | 4.76 | 89.3 | Buyer-sourced | 3 | MARGINAL |
| AX-2026-041222 | Thymulin | WWB | WWB-2602-S2129 | 2026-Q2 | 98.76 | 3.36 | 105.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042763 | BPC-157 | GGPeps | GGPE-2605-B9821 | 2026-Q2 | 97.83 | 3.92 | 106.0 | Buyer-sourced | 1 | FAIL |